Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer
Interventions: DRUG: doxorubicin hydrochloride|DRUG: cyclophosphamide|BIOLOGICAL: bevacizumab|DRUG: paclitaxel|BIOLOGICAL: filgrastim|BIOLOGICAL: pegfilgrastim|RADIATION: radiation therapy|DRUG: tamoxifen citrate|DRUG: aromatase inhibition therapy
Sponsor: National Cancer Institute (NCI)